Remdesivir Not Yet Recruiting Phase 3 Trials for Coronavirus Disease 2019 (COVID‑19) Treatment

Indications	Status	Purpose	Phase
DBCOND0129755 (Coronavirus Disease 2019 (COVID‑19))	Not Yet Recruiting	Treatment	3

clinicaltrials.gov Identifier	Title	Drugs
NCT04832880	Factorial Randomized Trial of Rendesivir and Baricitinib Plus Dexamethasone for COVID-19 (the AMMURAVID Trial)	Baricitinib (DB11817) Dexamethasone (DB01234) Remdesivir (DB14761)
NCT04647669	World Health Organization (WHO) COVID-19 Solidarity Trial for COVID-19 Treatments	Acalabrutinib (DB11703) Interferon beta-1a (DB00060) Remdesivir (DB14761)